首页 › 基金 › Elmind Capital, LP › AMLX
Elmind Capital, LP 对 AMLX 的持仓历史
AMYLYX PHARMACEUTICALS INC · 医疗保健
Elmind Capital, LP 在 Q3 2026 的 13F 申报中披露持有 AMLX(AMYLYX PHARMACEUTICALS INC)894,760 股,市值约 US$26.0M,约占其申报组合的 6.45%,在其申报持仓中市值排名第 6 位。 Elmind Capital, LP 最近 4 个申报季度中有 4 个季度披露了 AMLX 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Elmind Capital, LP 对 AMLX 的持仓演变
Elmind Capital, LP 于 Q4 2025 首次披露 AMLX 持仓:112,000 股(约 US$1.4M)。 该持仓在 Q3 2026 达到峰值 894,760 股,市值约 US$26.0M。 在 4 次申报中,Elmind Capital, LP 1 次增持、0 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 894,760 股、市值约 US$26.0M,环比增持 782,760 股。。 持仓曾出现大幅变动:Q3 2026 增持约 699% (随后一个季度股价下跌 4%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 112.00K | $1.35M | 新进 |
| Q1 2026 | 112.00K | $1.56M | 持有 |
| Q2 2026 | 112.00K | $2.01M | 持有 |
| Q3 2026 | 894.76K | $26.04M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AMLX 与 13F 数据
AMLX(AMYLYX PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 AMLX,申报仓位最大的包括:PERCEPTIVE ADVISORS LLC (US$307.7M), TCG Crossover Management, LLC (US$181.7M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$158.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AMLX 的基金
- PERCEPTIVE ADVISORS LLC 10.57M 股 · $307.70M · Q3 2026
- TCG Crossover Management, LLC 6.24M 股 · $181.69M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 5.43M 股 · $157.97M · Q3 2026
- Saturn V Capital Management LP 4.47M 股 · $130.12M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 4.28M 股 · $124.53M · Q3 2026
- First Light Asset Management, LLC 3.99M 股 · $116.01M · Q3 2026
- Siren, L.L.C. 2.48M 股 · $72.19M · Q3 2026
- Commodore Capital LP 2.00M 股 · $58.20M · Q3 2026
- Boxer Capital Management, LLC 893.15K 股 · $25.99M · Q3 2026
- Rock Springs Capital Management LP 756.77K 股 · $22.02M · Q3 2026
- GREAT POINT PARTNERS LLC 700.00K 股 · $20.37M · Q3 2026
- Parkman Healthcare Partners LLC 675.10K 股 · $19.65M · Q3 2026
更多关于 Elmind Capital, LP
常见问题
How long has Elmind Capital, LP held AMLX?
Elmind Capital, LP has disclosed AMLX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Elmind Capital, LP's current position in AMLX?
As of Q3 2026, Elmind Capital, LP holds 894.76K shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $26.04M, representing 6.45% of its reported portfolio and ranking #6.
Has Elmind Capital, LP been buying or selling AMLX?
In the latest 13F filing (Q3 2026), Elmind Capital, LP increased its position in AMLX. The position peaked in Q3 2026 at 894.76K shares.
Which other funds hold AMLX?
Other major institutional holders of AMLX include PERCEPTIVE ADVISORS LLC, TCG Crossover Management, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.